Today, ISTH TV highlights several late breaking presentations at the ISTH 2017 Congress in Berlin, Germany. This episode is entitled “Late Breaking Results in Hemophilia: Putting the Science to Practice.” Two new studies on emicizumab, HAVEN-1 and HAVEN-2, are discussed in this episode. The program also covers key information released on the Explorer 3 trial with concizumab and a phase 2 study with fitusiran. Join our host Thomas Baldrick and Professors Tiede, Oldenburg, and Pasi for this important broadcast.

Share this story, choose your platform!